• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[卵巢癌:药物治疗的作用]

[Ovarian cancer: role of medical treatment].

作者信息

Cappelaere P, Chauvergne J, Guerrin J

出版信息

Bull Cancer. 1982;69(3):284-91.

PMID:7126897
Abstract

The objective of medical treatment is to define the most active regimen and to combine them with optimal efficiency in the overall management of ovarian cancer patients, according to the results of surgical examination and the radiotherapeutic possibilities. The chemotherapy of common epithelial tumours is basically composed of alkylating agent, adriamycin, cis-platinum and hexamethylmelamine. The combination of these drugs leads to a high rate of surgically controlled tumor regressions and more complete responses, the only treatment which significantly increases survival. Results are less efficient for relapses or after failure of first line chemotherapy. The adjuvant chemotherapy of malignant germ cell tumours is used more and more often. The present indications of hormonotherapy are limited. Immunostimulant agents are being studied by several assays and preliminary results are interesting.

摘要

医学治疗的目标是根据手术检查结果和放射治疗的可能性,确定最有效的治疗方案,并以最佳效率将其结合用于卵巢癌患者的整体管理。常见上皮性肿瘤的化疗基本由烷基化剂、阿霉素、顺铂和六甲蜜胺组成。这些药物的联合使用导致手术控制的肿瘤退缩率很高,且反应更完全,这是唯一能显著提高生存率的治疗方法。对于复发或一线化疗失败后的情况,效果较差。恶性生殖细胞肿瘤的辅助化疗使用得越来越频繁。目前激素疗法的适应证有限。几种试验正在研究免疫刺激剂,初步结果令人感兴趣。

相似文献

1
[Ovarian cancer: role of medical treatment].[卵巢癌:药物治疗的作用]
Bull Cancer. 1982;69(3):284-91.
2
Medical therapy of advanced malignant epithelial tumours of the ovary.晚期卵巢恶性上皮性肿瘤的医学治疗
Forum (Genova). 2000 Oct-Dec;10(4):323-32.
3
Gynecological malignancies.妇科恶性肿瘤
Cancer Chemother Biol Response Modif. 1996;16:564-91.
4
[Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)].[临床实践指南:卵巢肿瘤患者一线医学治疗的标准、选择及建议(总结报告)]
Bull Cancer. 2004 Jul-Aug;91(7-8):609-20.
5
[Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].[卵巢癌的复发及二线治疗:传统全身治疗方式概述]
Zentralbl Gynakol. 1997;119(7):299-323.
6
Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.晚期卵巢癌的化疗:基于随机试验的当前护理标准
Gynecol Oncol. 1994 Dec;55(3 Pt 2):S97-107. doi: 10.1006/gyno.1994.1347.
7
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.复发侵袭性淋巴瘤的治疗:含与不含高剂量治疗及干细胞救援的方案
Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12.
8
Advances in the management of epithelial ovarian cancer.上皮性卵巢癌管理的进展
J Reprod Med. 2005 Jun;50(6):426-38.
9
Chemotherapy of advanced ovarian cancer.晚期卵巢癌的化疗
Front Biosci. 1997 Mar 15;2:g20-6.
10
Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.通过减瘤手术和体外耐药性检测指导的化疗对晚期卵巢癌女性进行经济有效的治疗。
Cancer J Sci Am. 1999 May-Jun;5(3):174-8.